Results 21 to 30 of about 19,681 (252)

Smoking Cessation Practices in Australian Oncology Settings: A Cross-Sectional Study of Who, How, and When. [PDF]

Asia Pac J Clin Oncol
The data on the smoking cessation practices of oncology HCPs found that differences existed between specialties and provision was more likely for those who had received training. A greater understanding of referral to behavioural support and pharmacotherapy is required through training for all staff involved in oncology patient care.
Young AL, McEnallay M, Day F, Vinod SK, Stone E, Morris S, Stefanovska E, Devitt B, Yip PY, Kukard C, Pal A, Thawal V, Wright G, Hofman A, Sareen H, McLennan J, Wong SO, Rubio C, Liu J, Smith A, Betts D, Mack J, Donnelly J, Paul C.   +23 more
europepmc   +2 more sources

Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Type 2 Diabetes

JAMA Network Open, 2022
This randomized clinical trial examines the effect of smoking cessation medication and counseling in smokers with type 2 diabetes.
C. Russo, Magdalena Walicka, P. Caponnetto, F. Cibella, Marilena Maglia, A. Alamo, D. Campagna, L. Frittitta, Maurizio Di Mauro, G. Caci, A. Krysiński, E. Franek, R. Polosa   +12 more
semanticscholar   +1 more source

Effect of Varenicline Added to Counseling on Smoking Cessation Among African American Daily Smokers: The Kick It at Swope IV Randomized Clinical Trial.

Journal of the American Medical Association (JAMA), 2022
Importance African American smokers have among the highest rates of tobacco-attributable morbidity and mortality in the US, and effective treatment is needed for all smoking levels.
L. Cox, Nicole L. Nollen, M. Mayo, B. Faseru, A. Greiner, E. Ellerbeck, R. Krebill, R. Tyndale, N. Benowitz, J. Ahluwalia   +9 more
semanticscholar   +1 more source

Cytisine versus varenicline for smoking cessation in New Zealand indigenous Māori: a randomized controlled trial

Addiction, 2021
Aim To determine whether cytisine was at least as effective as varenicline in supporting smoking abstinence for ≥ 6 months in New Zealand indigenous Māori or whānau (extended‐family) of Māori, given the high smoking prevalence in this population.
Natalie Walker, Barry Smith, J. Barnes, Marjolein E. A. Verbiest, V. Parag, S. Pokhrel, Mary-Kaye Wharakura, Tina Lees, Huber Cubillos Gutierrez, B. Jones, C. Bullen   +10 more
semanticscholar   +1 more source

Evaluating Treatment Mechanisms of Varenicline: Mediation by Affect and Craving.

Nicotine & Tobacco Research, 2022
INTRODUCTION Negative reinforcement models posit that relapse to cigarette smoking is driven in part by changes in affect and craving during the quit attempt.
S. Tonkin, C. Colder, M. Mahoney, G. Swan, P. Cinciripini, R. Schnoll, T. George, R. Tyndale, Larry W Hawk   +8 more
semanticscholar   +1 more source

Varenicline and Risk of Self-Harm: A Nested Case-Control Study. [PDF]

PLoS ONE, 2016
BACKGROUND:Smoking remains a serious public health concern. Pharmacotherapy for smoking cessation, including bupropion and varenicline, are proven means to increase quit rates.
Mina Tadrous, Diana Martins, Zhan Yao, Muhammad M Mamdani, David N Juurlink, Tara Gomes, Tony Antoniou   +6 more
doaj   +1 more source

Neural signatures of cognitive flexibility and reward sensitivity following nicotinic receptor stimulation in dependent smokers : a randomized trial [PDF]

, 2017
IMPORTANCE Withdrawal from nicotine is an important contributor to smoking relapse. Understanding how reward-based decision making is affected by abstinence and by pharmacotherapies such as nicotine replacement therapy and varenicline tartrate may aid ...
Aronson, Sarah E., Lesage, Elise, Ross, Thomas J., Salmeron, Betty Jo, Stein, Elliot A., Sutherland, Matthew T.   +5 more
core   +2 more sources

Semi-PBPK Modeling and Simulation to Evaluate the Local and Systemic Pharmacokinetics of OC-01(Varenicline) Nasal Spray

Frontiers in Pharmacology, 2022
This study aimed to build a nasal semi-physiologically based pharmacokinetic (PBPK) model to predict the intranasal pharmacokinetic (PK) of the OC-01(varenicline) nasal spray and accelerate the development of this drug.
Xiaofei Wu, Fan Zhang, Mengyang Yu, Faming Ding, Jinghui Luo, Bo Liu, Yuan Li, Zhiping Li, Hongyun Wang   +8 more
semanticscholar   +1 more source

The effectiveness, safety and cost-effectiveness of cytisine versus varenicline for smoking cessation in an Australian population: a study protocol for a randomized controlled non-inferiority trial [PDF]

, 2019
Smoking cessation medications are effective but often underutilised because of costs and side effects. Cytisine is a plant-based smoking cessation medication with over 50 years of use in Central and Eastern Europe.
Boland, Veronica C., Courtney, Ryan J., Doran, Christopher M., Farrell, Michael, Ferguson, Stuart G., Gartner, Coral, Hall, Wayne, Mattick, Richard P., McRobbie, Hayden, Mendelsohn, Colin P., Paul, Christine, Petrie, Dennis, Richmond, Robyn, Shakeshaft, Anthony, Siahpush, Mohammad, Thomas, Dennis, Tutka, Piotr, Walker, Natalie, West, Robert, Zwar, Nicholas   +19 more
core   +1 more source

Effects of Combined Varenicline With Nicotine Patch and of Extended Treatment Duration on Smoking Cessation: A Randomized Clinical Trial.

Journal of the American Medical Association (JAMA), 2021
Importance Smoking cessation medications are routinely used in health care. Research suggests that combining varenicline with the nicotine patch, extending the duration of varenicline treatment, or both, may increase cessation effectiveness.
T. Baker, Megan E. Piper, Stevens S. Smith, D. Bolt, J. Stein, M. Fiore   +5 more
semanticscholar   +1 more source